Site-specific initiation of a DNA fragment.

Site-specific initiation of a DNA fragment: nucleotide sequence of the bacteriophage G4 negative-strand initiation site. Proc Natl Acad Sci U S A (1978) 1.57

Deoxyribonucleic acid repair in bacteriophage. Microbiol Rev (1981) 1.32

DNA requirements at the bacteriophage G4 origin of complementary-strand DNA synthesis. J Virol (1986) 0.82

Electron microscopic analysis of partially replicated bacteriophage T7 DNA. J Virol (1979) 0.82

Quantitative film detection of 3H and 14C in polyacrylamide gels by fluorography. Eur J Biochem (1975) 56.72

A restriction enzyme from Hemophilus influenzae. I. Purification and general properties. J Mol Biol (1970) 19.69

Purification and further properties of single-strand-specific nuclease from Aspergillus oryzae. Eur J Biochem (1973) 13.54

Escherichia coli mutants temperature-sensitive for DNA synthesis. Mol Gen Genet (1971) 9.85

Discontinuities in the DNA synthesized in an excision-defective strain of Escherichia coli following ultraviolet irradiation. J Mol Biol (1968) 9.04

A nuclease specific for heat-denatured DNA in isolated from a product of Aspergillus oryzae. Biochim Biophys Acta (1966) 9.00

Specific fragments of phi X174 deoxyribonucleic acid produced by a restriction enzyme from Haemophilus aegyptius, endonuclease Z. J Virol (1972) 8.22

Multienzyme systems of DNA replication. Science (1974) 3.66

Conversion of phiX174 viral DNA to double-stranded form by purified Escherichia coli proteins. Proc Natl Acad Sci U S A (1974) 3.52

Mutants of bacteriophage S13 blocked in infectious DNA synthesis. J Mol Biol (1966) 3.36

dnaG gene product, a rifampicin-resistant RNA polymerase, initiates the conversion of a single-stranded coliphage DNA to its duplex replicative form. J Biol Chem (1975) 2.99

Migration of Escherichia coli dnaB protein on the template DNA strand as a mechanism in initiating DNA replication. Proc Natl Acad Sci U S A (1977) 2.03

Evolution of phi-chi 174. Isolation of four new phi-chi-like phages and comparison with phi-chi 174. Virology (1974) 1.99

Molecular mechanisms of induced mutagenesis. Replication in vivo of bacteriophage phiX174 single-stranded, ultraviolet light-irradiated DNA in intact and irradiated host cells. J Mol Biol (1977) 1.78

Susceptibility of the phiX-like phages G4 and G14 to R-EcoRi endonuclease. Virology (1974) 1.71

Replication of phage G4. A novel and simple system for the initiation of deoxyribonucleic acid synthesis. J Biol Chem (1975) 1.69

A coat protein of the bacteriophage M13 virion participates in membrane-oriented synthesis of DNA. Proc Natl Acad Sci U S A (1973) 1.57

A role for single-strand breaks in bacteriophage phi-X174 genetic recombination. J Mol Biol (1974) 1.48

The gene H spike protein of bacteriophages phiX174 and S13. I. Functions in phage-receptor recognition and in transfection. Virology (1975) 1.32

Structure of nascent phiX174 replicative form: evidence for discontinuous DNA replication. Proc Natl Acad Sci U S A (1974) 1.32

The interaction of phage S13 with ultraviolet-irradiated host cells and properties of the ultraviolet-irradiated phage. Virology (1960) 1.27

The gene H spike protein of bacteriophages phiX174 and S13. II. Relation to synthesis of the parenteral replicative form. Virology (1975) 1.20

The nucleolus and the rolling circle. Cold Spring Harb Symp Quant Biol (1974) 1.17

Effect of ultraviolet irradiation of bacteriophage f1 DNA on its conversion to replicative form by extracts of Escherichia coli. Mol Gen Genet (1976) 1.11

Evolution of phi chi 174. II. A cleavage map of the G4 phage genome and comparison with the cleavage map of phi chi 174. Virology (1975) 1.09

DNA replication: the rolling circle model. Cold Spring Harb Symp Quant Biol (1968) 8.37

Electric and magnetic stimulation of human motor cortex: surface EMG and single motor unit responses. J Physiol (1989) 5.69

Adenovirus-2 DNA contains an inverted terminal repetition. Proc Natl Acad Sci U S A (1972) 4.57

A potential noninvasive neurobiological test for Alzheimer's disease. Science (1994) 4.29

Molecular mechanisms in genetic recombination. Annu Rev Biochem (1982) 3.03

Initiation and reinitiation of DNA synthesis during replication of bacteriophage T7. Proc Natl Acad Sci U S A (1972) 2.95

Bacteriophage T7 DNA replication: a linear replicating intermediate (gradient centrifugation-electron microscopy-E. coli-DNA partial denaturation). Proc Natl Acad Sci U S A (1972) 2.87

Measles virus spread and pathogenesis in genetically modified mice. J Virol (1998) 2.84

On the mechanism of genetic recombination: electron microscopic observation of recombination intermediates. Proc Natl Acad Sci U S A (1976) 2.19

The amplification of ribosomal RNA genes involves a rolling circle intermediate. Proc Natl Acad Sci U S A (1973) 2.07

Brain parenchyma sonography discriminates Parkinson's disease and atypical parkinsonian syndromes. Neurology (2003) 1.89

dnaG (primase)-dependent origins of DNA replication. Nucleotide sequences of the negative strand initiation sites of bacteriophages St-1, phi K, and alpha 3. J Biol Chem (1979) 1.82

Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein. J Exp Med (1995) 1.74

Transfer factor. Ann Intern Med (1974) 1.65

Site-specific initiation of a DNA fragment: nucleotide sequence of the bacteriophage G4 negative-strand initiation site. Proc Natl Acad Sci U S A (1978) 1.57

Tacrolimus oral bioavailability doubles with coadministration of ketoconazole. Clin Pharmacol Ther (1997) 1.55

The rolling circle for phiX DNA replication. II. Synthesis of single-stranded circles. Proc Natl Acad Sci U S A (1970) 1.48

In vitro system from Escherichia coli that catalyzes generalized genetic recombination. Proc Natl Acad Sci U S A (1978) 1.40

Regions of single-stranded DNA in the growing points of replicating bacteriophage T7 chromosomes. Proc Natl Acad Sci U S A (1972) 1.37

Effect of digital nerve stimuli on responses to electrical or magnetic stimulation of the human brain. J Physiol (1992) 1.35

Sites within the complement C3b/C4b receptor important for the specificity of ligand binding. Proc Natl Acad Sci U S A (1991) 1.34

Analysis of the functional domains of complement receptor type 1 (C3b/C4b receptor; CD35) by substitution mutagenesis. J Biol Chem (1994) 1.24

On the mechanism of genetic recombination: the maturation of recombination intermediates. Proc Natl Acad Sci U S A (1977) 1.24

Analysis of the phiX DNA replication cycle by electron microscopy. Proc Natl Acad Sci U S A (1978) 1.19

The nucleolus and the rolling circle. Cold Spring Harb Symp Quant Biol (1974) 1.17

The rolling circle for phi X DNA replication. 3. Synthesis of supercoiled duplex rings. Proc Natl Acad Sci U S A (1970) 1.17

Botulinum toxin therapy of hemifacial spasm: comparing different therapeutic preparations. Eur J Neurol (2006) 1.15

Biochemical assay designed to detect formation of recombination intermediates in vitro. Proc Natl Acad Sci U S A (1979) 1.11

The pharmacokinetics and metabolic disposition of tacrolimus: a comparison across ethnic groups. Clin Pharmacol Ther (2001) 1.09

Complete secondary botulinum toxin therapy failure in blepharospasm. J Neurol (2000) 1.07

Transcranial electric and magnetic stimulation of the leg area of the human motor cortex: single motor unit and surface EMG responses in the tibialis anterior muscle. Electroencephalogr Clin Neurophysiol (1993) 1.07

Further observations on the facilitation of muscle responses to cortical stimulation by voluntary contraction. Electroencephalogr Clin Neurophysiol (1991) 1.04

A 'Southern Cross' method for the analysis of genome organization and the localization of transcription units. Gene (1986) 1.02

Effect of low- and high-fat meals on tacrolimus absorption following 5 mg single oral doses to healthy human subjects. J Clin Pharmacol (2001) 1.02

Transfer factor: a subcellular component that transmits information for specific immune responses. Proc Natl Acad Sci U S A (1974) 1.02

Nerve growth factor induces neuron-like differentiation of an insulin-secreting pancreatic beta cell line. Proc Natl Acad Sci U S A (1993) 1.01

On the chemical nature of transfer factor. Proc Natl Acad Sci U S A (1974) 0.98

Pharmacology of botulinum toxin: differences between type A preparations. Eur J Neurol (2006) 0.97

Sonographic detection of basal ganglia lesions in asymptomatic and symptomatic Wilson disease. Neurology (2005) 0.96

Effects of rifampin on tacrolimus pharmacokinetics in healthy volunteers. J Clin Pharmacol (1999) 0.96

Sonographic discrimination of corticobasal degeneration vs progressive supranuclear palsy. Neurology (2004) 0.94

Bacteriophage T7 DNA replication. An electron microscopic study of the growing point and the role of the T7 gene 4 protein in the formation of DNA fragments. J Biol Chem (1979) 0.92

Effect of time of meal consumption on bioavailability of a single oral 5 mg tacrolimus dose. J Clin Pharmacol (2001) 0.92

The rolling circle . capsid complex as an intermediate in phi X DNA replication and viral assembly. J Biol Chem (1980) 0.91

GPi-DBS may induce a hypokinetic gait disorder with freezing of gait in patients with dystonia. Neurology (2011) 0.91

Prospective study of selective peripheral denervation for botulinum-toxin resistant patients with cervical dystonia. Brain (2001) 0.90

Quantitation of free and total amphotericin B in human biologic matrices by a liquid chromatography tandem mass spectrometric method. Ther Drug Monit (2001) 0.89

Substantia nigra echogenicity is normal in non-extrapyramidal cerebral disorders but increased in Parkinson's disease. J Neural Transm (Vienna) (2002) 0.89

Higher prevalence of obsessive-compulsive symptoms in patients with blepharospasm than in patients with hemifacial spasm. Am J Psychiatry (1998) 0.88

New formulation of Botox: complete antibody-induced treatment failure in cervical dystonia. J Neurol Neurosurg Psychiatry (2007) 0.88

On muscle spindles, dystonia and botulinum toxin. Eur J Neurol (2010) 0.87

Demographic considerations in tacrolimus pharmacokinetics. Transplant Proc (1998) 0.87

Abnormal interaction between vestibular and voluntary head control in patients with spasmodic torticollis. Brain (2001) 0.87

Botulinum toxin therapy of writer's cramp. Eur J Neurol (2006) 0.87

Improvement in quality of life outcomes 2 weeks after left ventricular assist device implantation. J Heart Lung Transplant (2001) 0.87

Single-stranded phage replication: positive- and negative-strand DNA synthesis. Cold Spring Harb Symp Quant Biol (1979) 0.86

Systemic effect of local botulinum toxin injections unmasks subclinical Lambert-Eaton myasthenic syndrome. J Neurol Neurosurg Psychiatry (1993) 0.84

Expression of human decay accelerating factor or membrane cofactor protein genes on mouse cells inhibits lysis by human complement. Transpl Int (1992) 0.84

Spasmodic laryngeal dyspnea: a rare manifestation of laryngeal dystonia. Eur Arch Otorhinolaryngol (1997) 0.83

Primary sequence of an alternatively spliced form of CR1. Candidate for the 75,000 M(r) complement receptor expressed on chimpanzee erythrocytes. J Immunol (1994) 0.83

[Pathophysiological data and their consequences on diagnosis and therapy of degenerative joint diseases]. Med Monatsschr (1975) 0.83

The potential of BACE inhibitors for Alzheimer's therapy. Nat Biotechnol (2000) 0.83

Machado-Joseph disease presenting as severe generalised dystonia in a German patient. J Neurol (1999) 0.83

Clinical use of non-A botulinum toxins: botulinum toxin type C and botulinum toxin type F. Neurotox Res (2006) 0.83

[Anti-inflammatory action of a hyaluronic acid-chondroitin sulfate preparation in an in vitro bladder model]. Aktuelle Urol (2009) 0.82

Expression of human decay accelerating factor or membrane cofactor protein genes on mouse cells inhibits lysis by human complement. Transplant Proc (1992) 0.82

DNA recombination: in vivo and in vitro studies. Cold Spring Harb Symp Quant Biol (1979) 0.82

The recent excitement in the DNA growing point problem. Annu Rev Microbiol (1975) 0.82

Characterization of the promoter region of the membrane cofactor protein (CD46) gene of the human complement system and comparison to a membrane cofactor protein-like genetic element. J Immunol (1993) 0.82

Overactive bladder in Parkinson's disease: alteration of brainstem raphe detected by transcranial sonography. Eur J Neurol (2006) 0.81

Another case of focal segmental glomerulosclerosis in an acutely uraemic patient following interferon therapy. Nephrol Dial Transplant (1999) 0.81

Sonographic detection of basal ganglia abnormalities in spasmodic dysphonia. Eur J Neurol (2013) 0.81

The human factor H-related gene 2 (FHR2): structure and linkage to the coagulation factor XIIIb gene. Immunogenetics (1995) 0.81

Bioequivalence of 1 and 5 mg tacrolimus capsules using a replicate study design. J Clin Pharmacol (1999) 0.81

DNA synaptase: an enzyme that fuses DNA molecules at a region of homology. Proc Natl Acad Sci U S A (1980) 0.80

Rapid rate transcranial magnetic stimulation--a safety study. Electroencephalogr Clin Neurophysiol (1997) 0.80

Dysport produces intrinsically more swallowing problems than Botox: unexpected results from a conversion factor study in cervical dystonia. J Neurol Neurosurg Psychiatry (2002) 0.80

Transfer factor: warning on uncertainty of results. Ann Intern Med (1975) 0.79

Dyskinesias possibly induced by norpseudoephedrine. J Neurol (1994) 0.78

Authors' statement: the existence and nature of "transfer factor/be/. Proc Natl Acad Sci U S A (1975) 0.78

Changes of transcranially evoked motor responses in man by midazolam, a short acting benzodiazepine. Neurosci Lett (1989) 0.78

[Gout, pseudo-gout or hyperlipoproteinemia? (author's transl)]. Z Orthop Ihre Grenzgeb (1976) 0.78

Slow pre-movement cortical potentials do not reflect individual response to therapy in writer's cramp. Clin Neurophysiol (2009) 0.77

99mTc-hexamethylpropylene amine oxime SPECT and X-ray CT in acute cerebral ischaemia. J Neurol (1990) 0.77

Change in physical and psychosocial domains of quality of life from before to after discharge post left ventricular assist device implantation. J Heart Lung Transplant (2001) 0.77

Bioequivalence of a new strength tacrolimus capsule under development. Transplant Proc (1998) 0.76

Clozapine treatment of spasmodic torticollis. Neurology (1994) 0.76

The involvement of proteases, protease inhibitors, and an acute phase response in Alzheimer's disease. Ann N Y Acad Sci (1992) 0.76

Comparative tacrolimus pharmacokinetics: normal versus mildly hepatically impaired subjects. J Clin Pharmacol (2001) 0.76

Dose linearity after oral administration of tacrolimus 1-mg capsules at doses of 3, 7, and 10 mg. Clin Ther (1999) 0.76

[Dystonia as the cause of pharyngolaryngeal motility disorders]. HNO (1995) 0.75

[Intermittent apomorphine injections as rescue therapy for advanced Parkinson's disease. Consensus statement]. Nervenarzt (2008) 0.75

[Fractionated determination of central motor conduction times using stimulation of the cortex, spinal tract and spinal nerve roots: possibilities and limits]. EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb (1988) 0.75

[An improved model of a catheterised human bladder for screening bactericidal agents]. Aktuelle Urol (2008) 0.75

Significance of HMPAO-SPECT in the early diagnosis and followup of acute cerebral ischemia--comparison to CCT. Psychiatry Res (1989) 0.75

Asparagus and jejunal-through-PEG: an unhappy encounter in intrajejunal levodopa infusion therapy. Parkinsonism Relat Disord (2010) 0.75

[Botulinum toxin--the dose controls the poison. A historical sketch]. Nervenarzt (2002) 0.75

Botulinum toxin type B: where do we stand? Eur Neurol (2001) 0.75